Significant response of medullary thyroid cancer choroidal metastases to highly selective RET inhibitor selpercatinib: a case report

Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non–Small Cell Lung Cancers on the LIBRETTO-001 Trial

(2021) Vivek Subbiah et al.   CLINICAL CANCER RESEARCH

Efficacy of Selpercatinib in RET-Altered Thyroid Cancers

(2020) Lori J. Wirth et al.   NEW ENGLAND JOURNAL OF MEDICINE

Intraocular metastasis of medullary thyroid carcinoma investigated by transscleral fine-needle aspiration. A case report and review of the literature

(2018) Małgorzata Gajdzis et al.   DIAGNOSTIC CYTOPATHOLOGY

A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma

(2016) Cristina Romei et al.   Nature Reviews Endocrinology

Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma

(2015) Samuel A. Wells et al.   THYROID

Choroidal and Orbital Metastases from Thyroid Cancer

(2012) Nikola Besic et al.   THYROID

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER